FATE THERAPEUTICS

Codice
FATE
Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.78 -4.79 €
(-55.89%)
151065
P/E Obiettivo ad 1anno
0 7.83 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 4
Sell : 2

Genny cash AngerManagement

Commenti


Notizie

Hot Stocks Among Investors: Fate Therapeutics, Inc. (FATE), Oncobiologics, Inc. (ONS) - Post Analyst

Wall Street is only getting more bullish on the stock, with 7 of analysts who cover FATE having a buy-equivalent rating. Analysts have placed a $7.83 price target on Fate Therapeutics, Inc., suggesting a 126.96% gain from recent close. It's currently ... Leggi

Technical Roundup On Two Stocks - Fate Therapeutics, Inc. (FATE), Polymet Mining Corp. (PLM) - Post Analyst

Wall Street is only getting more bullish on the stock, with 7 of analysts who cover FATE having a buy-equivalent rating. Analysts have placed a $7.83 price target on Fate Therapeutics, Inc., suggesting a 115.11% gain from recent close. It's currently ...altro » Leggi

Investors Attention Alert: Mattel, Inc.'s (MAT), Fate Therapeutics, Inc.'s (FATE) - Is stories

Mattel, Inc. (MAT) closed business day at $21.75 with -0.64%. The firm exchanged a volume of 10.34 million shares at hands. In contrast, the average volume was 5.35 million shares. At the time of writing, Shares the company recently traded 0.93% away ...altro » Leggi

Hot Stocks Among Investors: Fate Therapeutics, Inc. (FATE), Western Refining, Inc. (WNR) - Post Analyst

Wall Street is only getting more bullish on the stock, with 7 of analysts who cover FATE having a buy-equivalent rating. Analysts have placed a $7 price target on Fate Therapeutics, Inc., suggesting a 76.32% gain from recent close. It's currently ...altro » Leggi

EcoR1 Capital, LLC Buys CytomX Therapeutics Inc, Cascadian Therapeutics Inc, Fate Therapeutics ... - Nasdaq

EcoR1 Capital, LLC initiated holdings in CytomX Therapeutics Inc. The purchase prices were between $10.71 and $18.89, with an estimated average price of $13.16. The stock is now traded at around $14.71. The impact to the portfolio due to this purchase ... Leggi

Oil States International, Inc. (OIS) At $28.70 Forms Top, 6 Bullish Analysts Covering Fate Therapeutics (FATE) - Bibeypost.com

The stock decreased 4.17% or $0.15 during the last trading session, reaching $3.45. About shares traded. Fate Therapeutics Inc (NASDAQ:FATE) has risen 166.12% since May 26, 2016 and is uptrending. It has outperformed by 149.42% the S&P500.altro » Leggi

Performance Check on Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Business Daily

We can now shift our focus to some alternate company data on shares of Fate Therapeutics, Inc. (NASDAQ:FATE). The stock has a current ATR of 0.24. When applying indicators for technical analysis, traders and investors may choose to examine the ATR or ...altro » Leggi

Stock's Price Moves: Cerus Corporation's (CERS), Fate Therapeutics, Inc.'s (FATE) ATR value stands at 0.24 - NYSE Journal (press release)

Currently the shares of Fate Therapeutics, Inc. (FATE) has a trading volume of 0.2 million shares and an average trading volume of 0.36 million shares. The volume of the particular stock is the shares bought and sold in a single trading day. The ...altro » Leggi

Fate Therapeutics (FATE) Receives Daily Media Sentiment Score of 0.04 - Stock Observer

Fate Therapeutics logo Media coverage about Fate Therapeutics (NASDAQ:FATE) has trended somewhat positive this week, AlphaOne reports. AlphaOne, a subsidiary of Accern, rates the sentiment of media coverage by reviewing more than 20 million blog and ... Leggi

Fate Therapeutics (FATE) Receiving Somewhat Negative News ... - Transcript Daily

Fate Therapeutics logo Press coverage about Fate Therapeutics (NASDAQ:FATE) has trended somewhat negative recently, Alpha One reports. Alpha One, a ... Leggi